Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amgen › Daniel J. Freeman
DF

Daniel J. Freeman — 15 Patents

AMAmgen: 14 patents #209 of 2,867Top 8%
DGDaiichi Sankyo Europe Gmbh: 3 patents #3 of 25Top 15%
UGU3 Pharma Gmbh: 3 patents #3 of 25Top 15%
DLDaiichi Sankyo Company, Limited: 2 patents #287 of 842Top 35%
KUKinki University: 1 patents #40 of 141Top 30%
Newbury Park, CA: #84 of 684 inventorsTop 15%
California: #40,789 of 386,348 inventorsTop 15%
Overall (All Time): #307,048 of 4,157,543Top 8%
15 Patents All Time
Daniel J. Freeman has been granted 15 US patents while listed as an inventor at Amgen. The first was granted in 2000 and the most recent in December 2025. Daniel J. Freeman ranks #307,048 of 4,157,543 US inventors in our database (top 7.4%). Patent records list Daniel J. Freeman in Newbury Park, CA, US.

Patents per Year

Patents granted per year, 2000 to 2024Bar chart with a peak of 2 patents in 2011.peak 22000: 1 patents20002011: 2 patents20112013: 1 patents20132014: 1 patents20142015: 2 patents20152017: 1 patents20172018: 2 patents20182021: 1 patents20212023: 1 patents20232024: 2 patents2024

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12497666 Nucleic acid biomarker and use thereof Marc Schneider, Sabine BLUM, Renee Jeanne MENDELL-HARARY, Robert Allen BECKMAN, Xiaoping Jin 2025-12-16
12139549 Material and methods for treating or preventing HER-3 associated diseases Thore Hettmann, Robert Radinsky 2024-11-12 $401,349,000
11873344 Protein biomarker and uses thereof Matthias Schneider, Sabine BLUM, Renee Jeanne MENDELL-HARARY, Robert Allen BECKMAN, Xiaoping Jin +2 more 2024-01-16
11840736 Nucleic acid biomarker and use thereof Matthias Schneider, Sabine BLUM, Renee Jeanne MENDELL-HARARY, Robert Allen BECKMAN, Xiaoping Jin 2023-12-12
11155876 K-ras mutations and anti-EGFr antibody therapy Todd Juan, Robert Radinsky 2021-10-26 $184,195,000
10030270 K-ras mutations and anti-EGFr antibody therapy Todd Juan, Robert Radinsky 2018-07-24 $464,817,000
9988462 Material and methods for treating or preventing HER-3 associated diseases Thore Hettmann, Robert Radinsky, Mike Rothe 2018-06-05
9803025 Material and methods for treating or preventing HER-3 associated diseases Thore Hettmann, Robert Radinsky 2017-10-31 $127,676,000
9101760 Material and methods for treating or preventing HER-3 associated diseases Thore Hettmann, Robert Radinsky 2015-08-11 $306,911,000
9097729 Methods of selecting epidermal growth factor receptor (EGFr) binding agents Jilin Sun, Kenneth Jung, Gary Elliott, Robert Radinsky 2015-08-04 $114,332,000
8771695 Antibodies directed to HER-3 and uses thereof Mike Rothe, Martin Treder, Susanne Hartmann, Robert Radinsky, Eric Borges 2014-07-08 $117,483,000
8546107 Epidermal growth factor receptor mutations Todd Juan, Robert Radinsky 2013-10-01 $234,067,000
7985559 Methods of selecting epidermal growth factor receptor (EGFR) binding agents Jilin Sun, Kenneth Jung, Gary Elliott, Robert Radinsky 2011-07-26 $211,082,000
7981605 Epidermal growth factor receptor mutations Todd Juan, Robert Radinsky 2011-07-19 $51,022,000
6022737 Formulations for non-viral in vivo transfection in the lungs Ralph Niven 2000-02-08 $389,181,000

Frequent Collaborators

Robert Radinsky11 shared
Todd Juan4 shared
Thore Hettmann4 shared
Renee Jeanne MENDELL-HARARY3 shared
Robert Allen BECKMAN3 shared
Sabine BLUM3 shared

Nearby-Ranked Inventors

Naoya Kasahara15
Aaron Larry Snyder15
Avishay Meron15
Stuart Hatfield15
Satoshi KUNIYASU15
Ashton Mason15
Theodore Yuchiang Cheng15
Richard Sharbaugh15
Rajen Bhatt15